← Research hub  ·  securities

DXYZ · Destiny Tech100 $30.85 -0.30 (-0.96%) 2026-SEP-18 12:48 EST

My allocationNot heldas of 2026-SEP-03 · allocation page ↗
Research: QT · SA · STK · FA3 mentions
2026-JUN-21 · Jay Singh · Weekly SSR research call (premium) · Negativeinsight · source page ↗$28.67

In short: Heavily short (with VCX): a listed pre-IPO fund with concentrated OpenAI/Anthropic secondaries, de-rating as enterprise-AI moats look weaker than hyped.

Full passage: premium transcript (PDF).

SOD $28.67 (open 2026-JUN-18)
2026-JUN-14 · Jay Singh · Weekly SSR research call (premium) · Neutralmention · source page ↗$38.50

In short: Referenced as one of the less-liquid listed pre-IPO funds (with VCX/PWRL) — far thinner than SATS, which is why hedgers used SATS options instead.

Full passage: premium transcript (PDF).

SOD $38.50 (open 2026-JUN-12)
2026-JUN-11 · Jay Singh · The David Lin Report (David Lin) · Neutralmention · ▶ 51:07 · source page ↗$37.50

In short: Named as another listed pre-IPO venture fund in the VCX genre (with newcomer PWRL) — VCX was simply "the most overvalued one in the market."

51:07most overvalued one in the market was this VCX in fact we had tweeted about it if you look at our timeline back in March it was trading at $565 a share or roughly 40 times its stated NAV over 40 times stated nav of about $20 a share. and we started to get short around once the options were listed around 300 a share at in March a couple different times.

SOD $37.50

Nothing matches this filter.

Verbatim excerpts from the public transcripts (auto-pulled at each mention's timestamp, lightly cleaned). Timestamps link into the video; "source page" opens that commentator's full analysis at this row. Click a mention's header line to expand it (one open at a time). For personal study — not investment advice.